A recent study indicates the crucial role of exosomal Cx43 in chemotherapy resistance and migration of glioma cells suggesting that Cx43 may hold promise as a therapeutic target for glioblastoma [59]. This evidence concerns the gene GJA1 and central nervous system cancer.